Novo Nordisk CEO to exit role
Current market conditions in the pharmaceutical industry have driven the…
Current market conditions in the pharmaceutical industry have driven the change to its executive leadership team, according to Novo Nordisk.
List view / Grid view
Current market conditions in the pharmaceutical industry have driven the…
Current market conditions in the pharmaceutical industry have driven the change to its executive leadership team, according to Novo Nordisk.
7% sales growth in local currencies driven by Levemir® and…
1 May 2014 | By Novo Nordisk
7% sales growth in local currencies driven by Levemir® and Victoza®...
Sales growth of 8% driven by Victoza®, Levemir® og NovoRapid®...
31 October 2013 | By Novo Nordisk
Sales growth of 8% driven by Victoza®, Levemir® og NovoRapid®...
Sales growth of 11% driven by Victoza®, NovoRapid® and Levemir®...
8 August 2013 | By Novo Nordisk
Sales growth of 11% driven by Victoza®, NovoRapid® and Levemir®...
The World Health Assembly unanimously adopted a global action plan...
30 May 2013 | By Novo Nordisk
The World Health Assembly unanimously adopted a global action plan...
The first-ever Diabetes Forum takes place in Mexico City (9th…
9 April 2013 | By Novo Nordisk
The first-ever Diabetes Forum takes place in Mexico City (9th April), to address the critical diabetes challenge the country is facing...
“We are convinced that Tresiba® and Ryzodeg® offer significant benefits...”
10 February 2013 | By Novo Nordisk
“We are convinced that Tresiba® and Ryzodeg® offer significant benefits...”
Sales growth of 18% driven by Victoza®, NovoRapid® and Levemir®...
31 January 2013 | By Novo Nordisk
Sales growth of 18% driven by Victoza®, NovoRapid® and Levemir®...
New numbers on the prevalence of diabetes have been launched...
14 November 2012 | By Novo Nordisk
New numbers on the prevalence of diabetes have been launched...
Sales grew 18% driven by Victoza®, NovoRapid® and Levemir®...
31 October 2012 | By Novo Nordisk
Sales grew 18% driven by Victoza®, NovoRapid® and Levemir®...
Sales grew 17% driven by Victoza®, NovoRapid® and Levemir®...
9 August 2012 | By Novo Nordisk
Sales grew 17% driven by Victoza®, NovoRapid® and Levemir®...
On World Diabetes Day, new numbers on the prevalence of…
14 November 2011 | By Novo Nordisk
On World Diabetes Day, new numbers on the prevalence of diabetes have been released by the IDF...